r/nsclc

+ 1.41%

non small cell lung cancer

Subscribers

791

Comments

378

Submissions

32.4K

New Subscribers

New Comments

New Total Posts

469

New Upvotes

886

Related Communities to r/nsclc

NSFW

Communities with similar interests and overlapping user engagementSort by Engagement

cancer

lymphoma

kidneycancer

Osteosarcoma

multiplemyeloma

pancreaticcancer

rectalcancer

melahomies

polycythemiavera

hodgkins_lymphoma

LungCancerSupport

ovariancancer_new

neuroendocrinetumors

Optimal Posting Schedule for r/nsclc

Strategic timing analysis to maximize your content's visibility and engagement

Best time of day to post on subreddit r/nsclc

Top performing posting times on r/nsclc in a

Analyze Other Subreddits

Discover insights and analyze other subreddits to find opportunities for growth and engagement.

Discover & Analyze r/nsclc

Community Insights

Related Communities

r/nsclc

Most Shared Resources in r/nsclc

URLs are hidden

Trending Content in r/nsclc

Life-Saving Surgery in Lung Cancer May Be Uncovered Through Information-Seeking

Quality of complex care in the Netherlands

Iron overload enhances the susceptibility to cysteine deprivation-induced ferroptosis in non-small cell lung cancer cells

The development and applications of circulating tumour cells, circulating tumour DNA and other emerging biomarkers for early cancer detection

The impact of EGFR mutation and PD-L1 status on the efficacy of postoperative radiotherapy in stage III-pN2 NSCLC

Molecular Assay May Help Identify People With Non-Small Cell Lung Cancer Who Could Benefit From Adjuvant Chemotherapy

Durable complete response in leptomeningeal disease of EGFR mutated non-small cell lung cancer to amivantamab, an EGFR-MET receptor bispecific antibody, after progressing on osimertinib

Reactivation of Mutant p53 in NSCLC: Cytotoxic Potential of PRIMA-1(Met) and Etoposide Combination

: Right Ventricular Dysfunction Is Associated with Mortality in Non-Small Cell Lung Cancer

Nivolumab plus ipilimumab with chemotherapy as first-line treatment of patients with metastatic non-small-cell lung cancer: final, 6-year outcomes from CheckMate 9LA